Global Analgesics Market Overview:
Global Analgesics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Analgesics Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Analgesics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Analgesics Market:
The Analgesics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Analgesics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Analgesics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Analgesics market has been segmented into:
Prescription
OTC
By Application, Analgesics market has been segmented into:
Opioids
NSAIDs
Other Drug Classes
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Analgesics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Analgesics market.
Top Key Players Covered in Analgesics market are:
Bristol-Myers Squibb Company
Bayer AG
Biological E. Ltd.
Anabolic Laboratories LLC
BioDelivery Sciences International Inc.
Brawn Laboratories Ltd.
Angelini Holding S.p.A.
AFT Pharmaceuticals Limited
APT Asia Pacific
Church & Dwight (Australia) Pty Ltd.
Alliance Design and Development Group Inc.
Active Releaf Wellness Inc.
Abiogen Pharma S.p.A.
B-New Limited
Celgene Corporation
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Analgesics Market Type
4.1 Analgesics Market Snapshot and Growth Engine
4.2 Analgesics Market Overview
4.3 Prescription
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Prescription: Geographic Segmentation Analysis
4.4 OTC
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 OTC: Geographic Segmentation Analysis
Chapter 5: Analgesics Market Application
5.1 Analgesics Market Snapshot and Growth Engine
5.2 Analgesics Market Overview
5.3 Opioids
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Opioids: Geographic Segmentation Analysis
5.4 NSAIDs
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 NSAIDs: Geographic Segmentation Analysis
5.5 Other Drug Classes
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Other Drug Classes: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Analgesics Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BRISTOL-MYERS SQUIBB COMPANY; BAYER AG; BIOLOGICAL E. LTD.; ANABOLIC LABORATORIES LLC; BIODELIVERY SCIENCES INTERNATIONAL
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; BRAWN LABORATORIES LTD.; ANGELINI HOLDING S.P.A.; AFT PHARMACEUTICALS LIMITED; APT ASIA PACIFIC; CHURCH & DWIGHT (AUSTRALIA) PTY LTD.; ALLIANCE DESIGN AND DEVELOPMENT GROUP
6.4 INC.; ACTIVE RELEAF WELLNESS INC.; ABIOGEN PHARMA S.P.A.; B-NEW LIMITED; CELGENE CORPORATION
Chapter 7: Global Analgesics Market By Region
7.1 Overview
7.2. North America Analgesics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Prescription
7.2.2.2 OTC
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Opioids
7.2.3.2 NSAIDs
7.2.3.3 Other Drug Classes
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Analgesics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Prescription
7.3.2.2 OTC
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Opioids
7.3.3.2 NSAIDs
7.3.3.3 Other Drug Classes
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Analgesics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Prescription
7.4.2.2 OTC
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Opioids
7.4.3.2 NSAIDs
7.4.3.3 Other Drug Classes
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Analgesics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Prescription
7.5.2.2 OTC
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Opioids
7.5.3.2 NSAIDs
7.5.3.3 Other Drug Classes
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Analgesics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Prescription
7.6.2.2 OTC
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Opioids
7.6.3.2 NSAIDs
7.6.3.3 Other Drug Classes
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Analgesics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Prescription
7.7.2.2 OTC
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Opioids
7.7.3.2 NSAIDs
7.7.3.3 Other Drug Classes
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Analgesics Scope:
|
Report Data
|
Analgesics Market
|
|
Analgesics Market Size in 2025
|
USD XX million
|
|
Analgesics CAGR 2025 - 2032
|
XX%
|
|
Analgesics Base Year
|
2024
|
|
Analgesics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Bristol-Myers Squibb Company, Bayer AG, Biological E. Ltd., Anabolic Laboratories LLC, BioDelivery Sciences International Inc., Brawn Laboratories Ltd., Angelini Holding S.p.A., AFT Pharmaceuticals Limited, APT Asia Pacific, Church & Dwight (Australia) Pty Ltd., Alliance Design and Development Group Inc., Active Releaf Wellness Inc., Abiogen Pharma S.p.A., B-New Limited, Celgene Corporation.
|
|
Key Segments
|
By Type
Prescription
OTC
By Applications
Opioids
NSAIDs
Other Drug Classes
|
